UPDATE: USPTO Board Rules for PacBio in Patent Interference Case with Life Technologies | GenomeWeb

The story was updated to include a comment from Life Technologies.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences late Monday announced that a board of the US Patents and Trademark Office has ruled against Life Technologies in a patent interference claim in which PacBio was named the senior party.

As a result of the decision, all patent claims by Life Tech involved in the case were canceled, PacBio said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.